Repligen Corp (RGEN): Cost of Revenue
$352.01M
Year ended 2025-12-31
+0.6%
3-year compound annual growth
+17.6%
5-year compound annual growth
+25.9%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $352.01M | -2.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $359.79M | +1.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $353.92M | +2.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $345.83M | +23.8% | 2025-03-14, From 2022-01-01 |
| 2021-12-31 | $279.28M | +78.3% | 2024-11-18, From 2021-01-01 |
| 2020-12-31 | $156.63M | +31.5% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $119.10M | +37.6% | 2022-02-17, From 2019-01-01 |
| 2018-12-31 | $86.53M | +29.1% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $67.05M | +42.3% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $47.12M | +33.7% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $35.25M | +25.8% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $28.02M | +24.6% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $22.48M | -9.9% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $24.96M | n/a | 2015-03-17, From 2012-01-01 |
| No annual figure between 2011-03-31 and 2012-12-31. | |||
| 2011-03-31 | $5.58M | +34.2% | 2013-03-15, From 2010-04-01 |
| 2010-03-31 | $4.16M | n/a | 2012-03-15, From 2009-04-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Repligen Corp (RGEN) | 2025-12-31 | $352.01M | -2.2% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $19.07M | +55.5% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $217.41M | +5.1% |
| Novavax Inc (NVAX) | 2025-12-31 | $73.04M | -64.0% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $415.97M | -3.1% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $5.09M | +86.3% |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $228.77M | +43.5% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $185.57M | +3.3% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $868.00M | -40.7% |
Compare RGEN, BCRX, ADMA, NVAX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗